Neuropathic Pain Clinical Trials

Neuropathic pain, a condition characterized by pain arising as a direct consequence of a lesion or disease affecting the somatosensory system, represents a significant clinical challenge and area of ongoing research.

Historically, neuropathic pain was poorly understood, with treatments focusing on symptom management without addressing underlying causes. Over time, advances in neuroscience have illuminated the complex mechanisms behind neuropathic pain, including the roles of the peripheral and central nervous systems, leading to more targeted and effective treatments.


Neuropathic pain affects approx.

7-10%

of the general population worldwide





About 60-70% of patients experience symptoms for more than

5 years

 



Neuropathic pain significantly impairs quality of life, affecting physical, emotional, and social well-being



 

Our clinical team has over

120

years of combined clinical trial experience

 

Download Our Paper

Fill out this form to download our white paper on how to overcome the biggest obstacles in conducting a neuropathic pain clinical trial.

iNGENū CRO - Neuropathic Pain

In light of the significant impact neuropathic pain has on individuals and society as a whole, continued research and awareness efforts are crucial to improve diagnosis, treatment, and ultimately, the quality of life for those living with this condition.

The development of clinical trial protocols that meet FDA approval standards is crucial for the success of new neuropathic pain treatments.